Enovis (ENOV) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Enovis (ENOV) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn | 17.92% |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 33.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 33.63% |
| Apr 3, 2026 | 26.43% |
| Dec 31, 2025 | -485.40% |
| Oct 3, 2025 | -93.47% |
| Jul 4, 2025 | -30.46% |
| Apr 4, 2025 | -15.01% |
| Dec 31, 2024 | -201.55% |
| Sep 27, 2024 | -28.18% |
| Jun 28, 2024 | 15.86% |
| Mar 29, 2024 | -61.64% |
| Dec 31, 2023 | 27.10% |
| Sep 29, 2023 | -39.26% |
| Jun 30, 2023 | 16.51% |
| Mar 31, 2023 | -49.77% |
| Dec 31, 2022 | -26.89% |
| Sep 30, 2022 | -225.18% |
| Jul 1, 2022 | 140.22% |
| Apr 1, 2022 | -24.58% |
| Dec 31, 2021 | -61.35% |
| Oct 1, 2021 | -41.99% |